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acquired bacteraemia and ascertains the utilization of blood cultures (BCs). A primary objective was to understand how local differences
may affect interpretation of nationwide surveillance for bacteraemia. From the Danish Microbiology Database, we retrieved all BCs taken
between 2010 and 2013 and linked these to admission data from the National Patient Registry. In total, 4 587 295 admissions were
registered, and in 11%, at least one BC was taken. Almost 50% of BCs were taken at admission. The chance of having a BC taken
declined over the next days but increased after 4 days of admission. Data linkage identiﬁed 876 290 days on which at least one BC was
taken; 6.4% yielded positive results. Ten species, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae,
Enterococcus faecium, Enterococcus faecalis, Pseudomonas aeruginosa, Candida albicans, Enterobacter cloacae and Klebsiella oxytoca, accounted
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knowledge for interpretation of surveillance of invasive infections more generally.
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p://dx.doi.org/10.1016/j.cmi.2014.11.018IntroductionBacteraemia is a severe condition associated with high mortality
[1–5]. Blood cultures (BCs) continue to be the only practical
method to diagnose bacteraemia [6]. Since 1 January 2010 theious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Gubbels et al. Utilization of blood cultures 344.e14Danish Microbiology Database (MiBa) has collected microbio-
logical test results from all departments of clinical microbiology
(DCMs) in Denmark [7]. This provided the unique opportunity
to study BC utilization on a national level. Combining these data
with administrative information from the National Patient
Registry (NPR [8]) allowed us to also study BCs in relation to
hospital admissions.
It is of fundamental interest to study the epidemiology and
utilization of BCs to evaluate clinical practices and to under-
stand trends observed in surveillance for invasive infections,
including those acquired in healthcare. Differences in BC utili-
zation, e.g. between laboratories, patient populations and
changes over time, may give rise to artefacts in surveillance
systems due to different levels of ascertainment. We conducted
a national population-based study describing the utilization of
BCs in Denmark to understand to which extent local differ-
ences may affect the interpretation of surveillance of bacter-
aemia. This assessment was done as part of the development of
an automated surveillance system for hospital-acquired in-
fections in Denmark; such a system will depend on a meaningful
pooling of data from various DCMs.MethodsData sources
MiBa is a real-time database that automatically receives a copy
of every electronic microbiology report delivered by all Danish
DCMs [7]. An extract from MiBa was obtained comprising all
BCs with a sampling date between 1 January 2010 and 31
December 2013. This extract included the sampling date and
time (the latter if available), cultured microorganisms and the
DCM that carried out the test. Each patient was identiﬁed in
MiBa through the civil registration (CPR) number, a unique
identiﬁer given to each person living in Denmark encrypting
date of birth and sex [9].
In January 2010 Denmark had 13 DCMs. Although remaining
independent DCMs, the laboratory information systems of the
DCMs in Herlev and Hvidovre merged in May 2012, and the
DCM in Hillerød joined this mutual data server in May 2013. In
January 2013 the DCMs in Herning and Viborg merged. For this
article, the DCMs were analysed in the new composition
(named by their geographic location).
The NPR includes administrative data on somatic inpatients
since 1977 [8]. Individual patients were identiﬁed through the
CPR number. We used an extract comprising patient admin-
istrative data between 1 January 2010 and 31 December 2013.
Only those patients who were admitted and discharged within
this period were selected; others were excluded, as these
would affect analyses on BCs in relation to the number of daysClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infesince admission. Data included date and time of admission and
discharge and the responsible departments and hospitals. The
NPR included one record for each admission to a department;
each time a patient was transferred to another department, this
was registered as a new record. We developed an algorithm
relating these inpatient transfers to form a complete course of
admission, here referred to as an admission.
The data from MiBa and NPR were linked using the CPR
number. Patients with temporary CPR numbers, such as foreign
travellers, were excluded from analysis. Similarly, those CPR
numbers derived from MiBa which led to an age calculation of
<0 or 100 years were excluded, as we could not conﬁrm
whether these CPR numbers were correct.
Deﬁnitions
To enable automatic classiﬁcation and avoid misclassiﬁcation of
contaminants as pathogens, we considered the following mi-
croorganisms as contaminants: Acinetobacter spp., Aerococcus
spp. (except A. urinae), Bacillus spp. (except B. anthracis and
B. cereus), Corynebacterium spp. (except C. diphtheriae), Lacto-
bacillus spp., Lactococcus spp., Micrococcus spp., Moraxella spp.
(except M. catarrhalis), Neisseria spp. (except N. animaloris, N.
canis, N. elongate, N. gonorrhoeae, N. zoodegmatis and
N. meningitidis), Propionibacterium acnes, Staphylococcus spp.
(except S. aureus, S. saprophyticus, S. lugdunensis and S. schleiferi).
Most DCMs identify Streptococcus spp. and nonhemolytic
streptoccocci to the species level, especially if the microor-
ganism is considered the etiological agent for bacteremia. Thus,
when reported at the genus level, ﬁndings were assessed as
contaminants.
Microorganisms not listed as contaminants were considered
pathogens.
A blood culture day (BCD) was deﬁned as a day on which a
patient had at least one blood sample taken for culture. The
reason for this measure was the practice in some DCMs to
register each bottle of a BC set as an individual sample, while
other laboratories registered a set of bottles. The time of
sampling was not always available, making it impossible to
distinguish between multiple bottles from one set and sets of
bottles drawn at different moments in time on the same day.
A positive BCD was deﬁned as a BCD on which at least one
culture yielded growth of at least one pathogenic
microorganism.
Data analysis
General demographics were described for patients who had
BCs taken. Age at ﬁrst blood sample and sex were derived from
the CPR number. BCDs and positive BCDs were observed
over time and by sex and age groups (0–4, 5–24, 25–44,
45–64, 65–74, 75–84 and 85–99 years). When stratifying byctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
344.e15 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIage group, the number of BCDs were calculated per 100 000
population, using population data from Denmark Statistics for
the ﬁrst quarter of 2012 (http://www.statistikbanken.dk/
statbank5a/selectvarval/saveselections.asp).
The ten most frequently found pathogenic microorganisms
were identiﬁed. These were determined by BCD, meaning that
different pathogenic species from the same BCD were included
but counted only once. Differences in the distribution of these
ten pathogenic microorganisms among the DCMs were ana-
lysed. Furthermore, the ﬁve most frequently found pathogenic
microorganisms were observed over time and stratiﬁed by age
group and sex of the patients.
BCDs and positive BCDs were studied in relation to ad-
missions and stratiﬁed by DCM. On the national level, BCDs,
positive BCDs and the percentage of positive BCDs were
studied over a period of 30 days since hospital admission, with
day 1 being the day of admission. In addition, BCDs and positive
BCDs were observed over this 30-day period per 100 patients
in hospital on each of the days since admission in order to
adjust for the fact that the number of patients decreases on the
days after admission.
Data management and analysis were performed by SAS
software (SAS Institute, Cary, NC, USA).
Ethical considerations
This study was approved by the Danish Data Protection Au-
thority as part of the development of the Danish HospitalClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectAcquired Infections Database (registration number 2012-41-
1269).ResultsA total of 408 179 unique patients had at least one BC taken
within the study period. Of these, 413 were excluded because
their CPR numbers led to an age calculation outside the 0- to
99-year age range. Finally, there were 407 766 patients, 205 417
(50.4%) men and 202 349 (49.6%) women. The mean age was
57 years (median 64 years).
Distribution by time and person
The total number of BCDs was 876 290; 55 992 (6.4%) of these
were positive BCDs. The number of BCDs increased slightly
over time for both men and women (Fig. 1). In addition, sea-
sonal variation occurred, with more BCDs in the winter
months. A slight general increasing trend was also seen for
positive BCDs, mostly for men. However, there was no sea-
sonal variation of positive BCDs, which means that the per-
centage of positive BCDs was lower during winter months.
Overall, the proportion of positive BCDs for men was 6.8% and
for women 5.9%. Over the entire period, more positive BCDs
were recorded for men.
Considering the incidence of BCDs among age groups, the
increase in BCDs and positive BCDs over the 4 years wasFIG. 1. Number of blood culture
(BC) days and positive BC days
stratiﬁed by sex between 2010 and
2013.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
CMI Gubbels et al. Utilization of blood cultures 344.e16mainly seen among patients aged 65 years and over. In these age
groups, seasonal variation was also observed, with a particularly
large peak in the winter of 2013. The youngest age group of
children (0–4 years) also showed a seasonal pattern in BCDs,
with more consistent increases in the winter. Seasonal variation
in positive BCDs was not distinctive in any age group.
Trends over time varied among DCMs. The general increase
in BCDs was observed for all, except for the DCM at the
university hospital and national referral centre, Rigshospitalet,
in Copenhagen, where a slight decrease was seen. The increases
were most considerable for the DCMs in Herlev/Hvidovre/
Hillerød, in Slagelse, Odense and in Aarhus. These DCMs, as
well as those in Aalborg and Herning/Viborg, also showed most
marked seasonal variation in BCDs. The DCMs in Herlev/Hvi-
dovre/Hillerød and Slagelse were the largest contributors to
the increase in positive BCDs.
Microbiological ﬁndings
The ten most frequently isolated pathogenic microorganisms
are presented in Table 1. Together, the top ten accounted for
74.7% of all pathogenic microorganisms. Of the bacterial spe-
cies that were considered contaminants, 77.2% were coagulase
negative staphylococci (excluding S. saprophyticus, S. lugdunensis
and S. schleiferi, as these were considered pathogens).
The DCM at Rigshospitalet saw a lower occurrence of E. coli
and S. pneumoniae than the other DCMs and a higher occur-
rence of E. faecium (Table 1). Otherwise, there were only small
variations in the distribution between the DCMs.
Increasing trends were seen for E. coli and S. aureus (Fig. 2).
These increasing trends affected both men and women, but
only in age groups of 65 years and older. S. pneumoniae showed
a clear seasonal variation, with increases during winter. This
trend was seen among men and women and in all age groups.
S. aureus, E. faecium and K. pneumoniae were more often found
among men (male:female ratio of 1.7:1.0, 1.6:1.0 and 1.6:1.0,TABLE 1. Ten most common pathogenic microorganisms per blood














n % n % n % n % n %
Aalborg 1814 41.2 738 16.7 395 9.0 391 8.9 198
Aarhus 2040 37.0 931 16.9 508 9.2 476 8.6 437
Esbjerg 628 39.8 279 17.7 139 8.8 122 7.7 67
Herlev/Hvidovre/
Hillerød
5339 42.1 2201 17.3 1110 8.7 1145 9.0 702
Herning/Viborg 1332 38.0 634 18.1 345 9.8 345 9.8 160
Odense 1616 32.8 787 16.0 415 8.4 324 6.6 568 1
Rigshospitalet 567 20.0 610 21.5 327 11.5 78 2.7 523 1
Slagelse 2676 42.1 1077 16.9 630 9.9 586 9.2 272
Sønderborg 577 45.2 224 17.5 116 9.1 108 8.5 48
Vejle 923 44.2 324 15.5 179 8.6 187 9.0 127
Total 17 512 38.7 7805 17.3 4164 9.2 3762 8.3 3102
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inferespectively), while E. coli and S. pneumoniae were found equally
among the sexes.
BCs in relation to admissions
Between 2010 and 2013 there were 4 587 295 admissions; in
506 797 of these (11%) there was at least one BCD. As patients
may be transferred to other hospitals, several DCMs may be
involved in culturing blood samples during the course of one
admission. For 498 245 admissions (98.3%), only one DCM was
recorded, for 8337 (1.7%) two, for 205 (0.04%) three and for
ten (<0.01%) four. If two DCMs were involved on the same day,
only the one that tested the ﬁrst sample was included in Table 2.
Of the total of 876 290 BCDs, 827 106 (94.4%) occurred during
an admission and 432 164 (49.3%) coincided with the day of
admission. The 5.6% of BCDs that were not taken during an
admission were taken during the 3 days before an admission or
up to 30 days after an admission. The percentage of positive
BCDs did not vary substantially between DCMs.
The number of BCDs decreased more after admission than
the number of positive BCDs, resulting in a percentage of
positive BCDs that showed an initial decrease but a steady in-
crease from day 4 since admission (Fig. 3A). The number of
BCDs and positive BCDs per 100 admitted patients also
showed an initial decrease, followed by a steady increase from
day 4 (Fig. 3B). When observing the ﬁve most common path-
ogens in relation to the admission, all showed a marked
decrease after the day of admission. Only E. faecium increased
again after day 5 and decreased after day 9.DiscussionThe availability of national microbiology data in combination
with admission data on all Danish patients created the unique











n % n % n % n % n % n
4.5 240 5.4 202 4.6 154 3.5 139 3.2 137 3.1 4408
7.9 330 6.0 229 4.1 217 3.9 179 3.2 173 3.1 5520
4.2 102 6.5 69 4.4 85 5.4 42 2.7 44 2.8 1577
5.5 812 6.4 439 3.5 298 2.3 317 2.5 326 2.6 12 689
4.6 285 8.1 121 3.4 70 2.0 97 2.8 120 3.4 3509
1.5 437 8.9 211 4.3 233 4.7 182 3.7 147 3.0 4920
8.4 245 8.6 114 4.0 168 5.9 132 4.6 78 2.7 2842
4.3 363 5.7 230 3.6 152 2.4 178 2.8 198 3.1 6362
3.8 77 6.0 37 2.9 22 1.7 36 2.8 32 2.5 1277
6.1 118 5.6 90 4.3 39 1.9 47 2.2 55 2.6 2089
6.9 3009 6.7 1742 3.9 1438 3.2 1349 3.0 1310 2.9 45 193
ctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
FIG. 2. Frequency of ﬁve most common pathogens per blood culture day between 2010 and 2013.
344.e17 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIthe utilization and general results of BCs in Denmark and to
analyse trends. This study showed increases in BC activity and
seasonality over the period between 1 January 2010 and 31
December 2013. It provided important insights in differences
between DCMs and among the patient population in terms of
age and sex. The BCDs and percentage of positive BCDs were
shown to decrease in the ﬁrst 4 days of admission and to in-
crease after that.
Our study was subject to several limitations. Because of
varying registration practices, we were unable to assess the
blood volume of each BC and distinguish culture sets (several
bottles for a BC obtained at one time point) from individual
culture bottles. The measure we used as a proxy, the BCD, may
therefore underestimate blood-culturing activity. However, itTABLE 2. Number of BCs and percentage of positive BC days i
microbiology between 2010 and 2013
Departments of clinical microbiology
BC days total BC
n % positive n
Aalborg 82 762 6.6 79
Aarhus 125 205 5.5 11
Esbjerg 31 991 5.9 30
Herlev/Hvidovre/Hillerød 216 717 7.2 20
Herning/Viborg 77 188 5.6 73
Odense 91 050 6.7 83
Rigshospitalet 67 660 5.5 62
Slagelse 113 766 6.9 10
Sønderborg 26 104 6.0 24
Vejle 43 847 5.9 40
Total 876 290 6.4 82
BC, blood culture.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectdoes reﬂect the daily decision by the clinical team to test a
patient for bacteraemia. The deﬁnition of positive BCDs will
also give rise to an underestimation, as the positive rate is
dependent on the volume of blood that was used for culture.
Another reason for underestimation is that the BCDs do not
include BCs where likely contaminants were repeatedly isolated
and hence could be ruled to be clinically relevant. Classifying all
nonspeciated streptococci as contaminants may also add to an
underestimation of positive BCDs, as may the classiﬁcation of
species commonly considered contaminants in Denmark, which
in rare cases may be etiologic agents (e.g. Acinetobacter bau-
manii). This was done to be certain that BCDs counted as
positive reﬂected well-deﬁned and true cases of bacteraemia
and not just contaminated samples. Conclusions drawn fromn relation to admission according to department of clinical
days during admission BC days at day of admission
% positive n % positive
175 6.6 42 070 7.6
6 953 5.6 59 598 6.7
487 6.0 17 489 6.6
5 932 7.3 113 921 7.9
557 5.6 42 618 6.6
592 6.9 38 009 8.0
225 5.7 15 152 8.1
9 842 6.9 65 868 7.6
498 6.2 13 248 7.5
845 6.1 24 191 7.2
7 106 6.5 432 164 7.4
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
(a)
(b)
FIG. 3. (a) Number of blood culture (BC) days, positive BC days and percentage of positive BC days in relation to days since admission between 2010
and 2013. (b) Number of BC days and positive BC days per 100 admitted patients in relation to days since admission between 1 January 2010 and 31
December 2013.
CMI Gubbels et al. Utilization of blood cultures 344.e18automated systems should be judged with caution, and our
rationale was to prioritize speciﬁcity while being aware that
absolute numbers of BCDs may be underestimated.
Lastly, numbers of positive vs. negative BCDs late in the
course of admission may be biased by clinicians’ attempts to
take repeated BCs until a negative appears, e.g. in cases of
endocarditis or candidemia. The magnitude and direction of this
bias is difﬁcult to assess.
For these reasons, the measures of BCDs and positive BCDs
may be difﬁcult to compare to other studies in absoluteClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infenumbers. They do, however, standardize the data and therefore
allow following trends over time and studying differences by age
group, sex and DCM.
To further understand differences between DCMs, it would
have been useful to assess patients’ clinical characteristics which
led to the decision to take a BC. However, these data were not
available from the sources used in the present study. It was also
not possible to group departments to which patients were
admitted by their specialty, e.g. to identify intensive care units,
departments of surgery, internal medicine and paediatrics. Thectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
344.e19 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMINPR and MiBa do provide the name of each speciﬁc depart-
ment. Nonetheless, these names do not always contain infor-
mation on the specialty, and the registries do not contain an
unambiguous classiﬁcation of the type of department. It would
also have been informative to analyse the ﬁndings for each
DCM in relation to the patient population it serves— for
example, in terms of number of patients and length of stay. This
information was, however, only available on a national level, not
by DCM. As a follow-up study, it would be of interest to apply a
comorbidity index based on ICD-10 codes from the NPR.
At the beginning of 2010, the increases observed in BCDs
and positive BCDs may have been due to the starting up phase
of MiBa, but the BC activity showed a steady increase over all 4
years, suggesting a real increase. The increasing trend is also in
line with other studies that have seen substantial increases in
incidence rates of bacteraemia over longer periods of time
[1,10–12]. This can partly be explained by an aging population.
Organizational changes in acute care in Danish hospitals, which
have taken place during the same period, may also have
contributed to the increase. Thirdly, the introduction of sepsis
packages in several Danish hospitals since April 2010, describing
interventions to reduce mortality from sepsis through correct
and timely diagnostics and treatment (http://www.
patientsikkertsygehus.dk/pakker/alle-pakker/sepsispakken.aspx),
can also be a reason for the increase in BC activity. The dif-
ferences in trends over time we observed between DCMs may
be due to differences in the patient population the DCMs
served, but other factors, such as BC methodology, also need
to be taken into account in the interpretation of time trends of
bacteraemia [13]. The general increase in positive BCDs was
mainly due to an increase in E. coli bacteraemias and to a lesser
extent to S. aureus bacteraemias. It would be interesting to
further investigate if the increase in E. coli included an increase
in extended-spectrum β-lactamase-producing bacteria. The
observed trends over time will need to be conﬁrmed using
time-series analysis when data become available for a longer
period of time.
The seasonal trends in BC activity with increases in the
winter coincided with the inﬂuenza seasons. The seasons of
2010–2011 and 2012–2013 had a higher inﬂuenza activity in
Denmark than the season of 2011–2012 [14]. Our data on the
BC activity show a similar trend with more marked increases in
the seasons of 2010–2011 and 2012–2013. An explanation
could be that patients admitted with fever and respiratory
symptoms are commonly tested for bacteraemia. The ﬁnding
that the seasonal variation was more marked in some DCMs
may suggest that some hospitals received more patients with
fever and respiratory symptoms than others and/or that some
hospitals have different practices for testing these patients. The
increase in BC testing did not lead to an increase in positive BCsClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectduring winter. Therefore, the percentage of positive BCs was
lower, suggesting that the decision to take a BC may be inﬂu-
enced by expectations of the clinical team or by the presence of
fever rather than signs and symptoms of bacterial vs. viral in-
fections. The occurrence of S. pneumoniae did show a seasonal
trend with peaks in the winter. This was not notable in the
overall picture of positive BCs because S. pneumoniae bacter-
aemias accounted for a small percentage of the total number of
positive BCs.
The number of positive BCDs was higher among men, which
is in line with other studies showing higher incidences of bac-
teraemia among men [11,15]. The higher number of positive
BCDs among men was mainly due to S. aureus, E. faecium and
K. pneumoniae. As mentioned before, once data are available for
a longer period of time, time-series analysis will allow conﬁr-
mation of these trends.
The ﬁnding of E. coli, S. aureus and K. pneumoniae as the most
common microorganisms was to be expected. Although an
upsurge of E. faecium is well described in Denmark, it was a
surprise that E. faecium was found to be more frequent than
E. faecalis [16,17]. This may have to do with the way we ana-
lysed the data, i.e. including a microorganism only once per
BCD.
Differences in the percentage of positive BCDs between the
DCMs were small. This ﬁnding is of importance for the con-
struction of a system for automated surveillance of nosocomial
bacteraemia. The upcoming automated system is based on the
rationale that data from different DCMs and patient populations
can be pooled meaningfully. The main outlier was the DCM at
Rigshospitalet, which is a tertiary hospital with highly specialized
national functions. This DCM had a different ranking of path-
ogens, which we cautiously ascribe to a different patient pop-
ulation with more comorbidities, complications and
susceptibility to opportunistic infections. Other variations be-
tween the DCMs may be due to differences in sample size,
timing of antimicrobial treatment, antibiotic treatment policies
and blood volume taken.
The number of BCDs during admission showed an expected
pattern, in which close to 50% of BCDs occurred on the day of
admission, followed by a decrease over the following days.
Moreover, the results of BCDs per 100 patients showed that
the risk of having a BC taken increases with longer admissions.
As the positive BCDs per 100 patients and the percentage
positive of BCDs also continued to increase, it can be
concluded from our data that the risk of getting bacteraemia
also increases with the length of stay. Many patients with sus-
pected invasive illness at admission will receive antimicrobial
treatment cover after 48 hours’ admission, and this may in part
explain the turning point we observed. Another explanation for
the increase from day 4 may be the occurrence of hospital-ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 344.e13–344.e21
CMI Gubbels et al. Utilization of blood cultures 344.e20acquired bacteraemia. The ﬁnding that E. faecium, which is often
found in hospital-acquired bacteraemias, increased at day 5 of
admission may further support this. Computer algorithms to
determine hospital-acquired bacteraemia showed 48 hours to
be a useful threshold [18–20]. Other studies have suggested 72
hours [21]. Our approach of showing positive BCDs per 100
patients and percentage of positive BCDs cannot give a clear
suggestion for the number of hours to be used as a threshold,
but the increases we observed after day 4 may strengthen the
previous assumptions that a threshold in a computer algorithm
can be used.
In conclusion, we observed an overall increase in BC utili-
zation and positive BCDs, most prominently among the older
age groups, and mostly caused by E. coli and to a lesser extent
S. aureus. The activity in terms of BCDs showed a seasonal
pattern, driven by negatives rather than positives, possibly
related to the inﬂuenza seasons and the seasonality of
S. pneumoniae. The distribution of pathogens differed among
DCMs, possibly due to differences in patient populations. A
predominance of men was seen for bacteraemias due to
S. aureus, E. faecium and K. pneumoniae. The proportion of
positive BCDs was similar between DCMs. It decreased in the
ﬁrst 4 days of admission and increased after that.
These trends and differences provide important insights,
which will soon be used to create a nationwide electronic
surveillance system for hospital-acquired bacteraemia, which
will show data for the whole country, as well as by region,
hospital and each individual clinical department. The minor
differences in the BCDs and positive BCDs among DCMs un-
derpin the rationale and meaningfulness of such a surveillance
system. Nonetheless, we found differences, particularly in the
ﬁndings of speciﬁc pathogens, which suggest that factors such as
clinical characteristics of the patient population are inﬂuencing
the results. The different patterns between age groups, sex and
DCMs that serve tertiary hospitals further illustrated this. This
is particularly important to keep in mind when attempting to
compare results from departments or hospitals with each other
or to regional and national results. It shows the need for age,
sex and comorbidity adjustment when standardizing national
surveillance statistics.
This type of analysis, in which routine databases are linked,
may also create opportunities for public health surveillance in
other countries, especially when they face restrictions on the
use of clinical databases for public health purposes. The study
provides important baseline data for the interpretation of
surveillance data for invasive infections more generally, in
particular when the aim is to compare surveillance ﬁgures
from various populations and healthcare systems, and
where case ascertainment is highly dependent on diagnostic
practices.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfeTransparency declarationAll authors report no conﬂicts of interest relevant to this
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